AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8149030 — intervention group
Group type: EXPERIMENTAL
Intervention: Single 1.5 gram dose of cefuroxime plus three doses of placebo
Number of subjects: 295
Study 8149030 — intervention group
Group type: COMPARATOR
Intervention: Four 1 gram doses of cefazolin
Number of subjects: 295
Study 3409623 — intervention group
Group type: EXPERIMENTAL
Intervention: Impedance plethysmography (QZp)
Number of subjects: 6
Study 3409623 — intervention group
Group type: EXPERIMENTAL
Intervention: Venous occlusion strain gauge plethysmography (Qsg)
Number of subjects: 6
Study 3409623 — intervention group
Group type: EXPERIMENTAL
Intervention: Venous occlusion plethysmography (QZocc)
Number of subjects: 6
Study 12206948 — intervention group
Group type: EXPERIMENTAL
Intervention: Low back pain patients under slow breathing (0.1 Hz)
Number of subjects: 20
Study 12206948 — intervention group
Group type: EXPERIMENTAL
Intervention: Low back pain patients under fast breathing (0.5 Hz)
Number of subjects: 20
Study 12206948 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects under slow breathing (0.1 Hz)
Number of subjects: 20
Study 12206948 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects under fast breathing (0.5 Hz)
Number of subjects: 20
Study 31083232 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain education-based meditation (BEM)
Number of subjects: 48
Study 31083232 — intervention group
Group type: COMPARATOR
Intervention: Health education classes
Number of subjects: 48
Study 30207526 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotretinoin, folic acid, and vitamin B12
Number of subjects: 66
Study 30207526 — intervention group
Group type: COMPARATOR
Intervention: Isotretinoin alone
Number of subjects: 66
Study 27909125 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 111
Study 25117066 — intervention group
Group type: EXPERIMENTAL
Intervention: PK-guided 5-FU dosing
Number of subjects: 70
Study 22985896 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.25% sodium hypochlorite (NaOCl)
Number of subjects: 126
Study 22985896 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine gel (CLX)
Number of subjects: 126
Study 20139674 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated infant growth
Number of subjects: 0
Study 20139674 — intervention group
Group type: COMPARATOR
Intervention: Normal infant growth
Number of subjects: 0
Study 18996244 — intervention group
Group type: EXPERIMENTAL
Intervention: AM-PAC Physical Mobility scale
Number of subjects: 108
Study 18996244 — intervention group
Group type: EXPERIMENTAL
Intervention: AM-PAC Personal Care scale
Number of subjects: 108
Study 18996244 — intervention group
Group type: EXPERIMENTAL
Intervention: SF-36 PF
Number of subjects: 108
Study 18996244 — intervention group
Group type: EXPERIMENTAL
Intervention: SPPB
Number of subjects: 108
Study 18996244 — intervention group
Group type: EXPERIMENTAL
Intervention: PFP-10
Number of subjects: 108
Study 18996244 — intervention group
Group type: EXPERIMENTAL
Intervention: Gait speed
Number of subjects: 108
Study 18996244 — intervention group
Group type: EXPERIMENTAL
Intervention: 6MWT
Number of subjects: 108
Study 15830986 — intervention group
Group type: EXPERIMENTAL
Intervention: Microdiscectomy
Number of subjects: 300
Study 15830986 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradiscal ozone injection
Number of subjects: 300
Study 15830986 — intervention group
Group type: COMPARATOR
Intervention: Microdiscectomy and Intradiscal ozone injection
Number of subjects: 300
Study 12439835 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 0
Study 12439835 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 0
Study 10348358 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-adrenergic blocking agent (phentolamine mesylate, 20 ml infused at 2 ml/min)
Number of subjects: 9
Study 10348358 — intervention group
Group type: COMPARATOR
Intervention: Placebo (physiological saline, 20 ml infused at 2 ml/min)
Number of subjects: 9
Study 8630553 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice guideline intervention
Number of subjects: 146
Study 8630553 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 146
Study 8630553 — intervention group
Group type: EXPERIMENTAL
Intervention: Both intervention and control groups
Number of subjects: 146
Study 1940488 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg oral morphine in fasted state
Number of subjects: 5
Study 1940488 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg oral morphine in fed state
Number of subjects: 5
Study 7146305 — intervention group
Group type: EXPERIMENTAL
Intervention: Foster Grandparent intervention
Number of subjects: 0
Study 7146305 — intervention group
Group type: COMPARATOR
Intervention: No visitors (Control)
Number of subjects: 0
Study 7146305 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent visitors
Number of subjects: 0
Study 30786906 — intervention group
Group type: EXPERIMENTAL
Intervention: Health educational intervention based on the IMB model
Number of subjects: 372
Study 30786906 — intervention group
Group type: COMPARATOR
Intervention: Health education on breastfeeding (Control)
Number of subjects: 372
Study 29871651 — intervention group
Group type: EXPERIMENTAL
Intervention: MEDIHEALTH program
Number of subjects: 0
Study 29871651 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 26313229 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg BR-DIM, twice daily
Number of subjects: 45
Study 26313229 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg BR-DIM, twice daily
Number of subjects: 45
Study 26313229 — intervention group
Group type: COMPARATOR
Intervention: Placebo, twice daily
Number of subjects: 45
Study 26313229 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg BR-DIM, twice daily
Number of subjects: 45
Study 23826649 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser
Number of subjects: 21
Study 23826649 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser
Number of subjects: 21
Study 22404223 — intervention group
Group type: COMPARATOR
Intervention: Contingency Management (CM) for abstinence alone
Number of subjects: 127
Study 22404223 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT) alone
Number of subjects: 127
Study 22404223 — intervention group
Group type: EXPERIMENTAL
Intervention: CM combined with CBT
Number of subjects: 127
Study 22404223 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT combined with CM
Number of subjects: 127
Study 19947264 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with TDP
Number of subjects: 112
Study 17711715 — intervention group
Group type: EXPERIMENTAL
Intervention: MCE-guided TASH
Number of subjects: 72
Study 17711715 — intervention group
Group type: COMPARATOR
Intervention: AP-guided TASH
Number of subjects: 72
Study 15144473 — intervention group
Group type: EXPERIMENTAL
Intervention: Myrmecia pilosula ant venom immunotherapy (VIT)
Number of subjects: 0
Study 15144473 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15144473 — intervention group
Group type: EXPERIMENTAL
Intervention: Various in vitro tests (IgE RAST, leucocyte SI, IL-4 production, LRT, BAT)
Number of subjects: 0
Study 12167382 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 46
Study 12167382 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 9646001 — intervention group
Group type: EXPERIMENTAL
Intervention: Method 1: Cotton-tipped swab and cervical brush for HPV testing
Number of subjects: 115
Study 9646001 — intervention group
Group type: COMPARATOR
Intervention: Method 2: Cyto standard cylindrical cytology brush and Dacron-tipped swab for HPV testing
Number of subjects: 115
Study 7641465 — intervention group
Group type: EXPERIMENTAL
Intervention: Total knee prosthetic designs with low to moderate conformity
Number of subjects: 0
Study 7641465 — intervention group
Group type: EXPERIMENTAL
Intervention: Total knee prosthetic designs with moderate to high conformity
Number of subjects: 0
Study 7641465 — intervention group
Group type: EXPERIMENTAL
Intervention: All designs tested
Number of subjects: 0
Study 2473995 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct inoculation of the Vitek AutoMicrobic system
Number of subjects: 226
Study 2473995 — intervention group
Group type: COMPARATOR
Intervention: Routine methods
Number of subjects: 226
Study 2473995 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct method
Number of subjects: 226
Study 779855 — intervention group
Group type: EXPERIMENTAL
Intervention: L-tryptophan
Number of subjects: 16
Study 31631859 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic supracervical hysterectomy
Number of subjects: 0
Study 31631859 — intervention group
Group type: COMPARATOR
Intervention: Endometrial ablation
Number of subjects: 0
Study 28292282 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic interval training plus healthy lifestyle counselling (16 supervised training lessons, 6 group and 3 individual meetings)
Number of subjects: 105
Study 28292282 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-to-moderate intensity continuous training plus healthy lifestyle counselling (16 supervised training lessons, 6 group and 3 individual meetings)
Number of subjects: 105
Study 28292282 — intervention group
Group type: COMPARATOR
Intervention: Healthy lifestyle counselling without any supervised physical exercise (6 group and 3 individual meetings)
Number of subjects: 105
Study 26054104 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric vacuum aspiration in UHR
Number of subjects: 392
Study 26054104 — intervention group
Group type: COMPARATOR
Intervention: Method chosen according to patients' features in UHS
Number of subjects: 392
Study 26054104 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis in UHR
Number of subjects: 392
Study 26054104 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical priming with Laminaria in UHS
Number of subjects: 392
Study 23463651 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training (AT)
Number of subjects: 52
Study 23463651 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (RT)
Number of subjects: 52
Study 23463651 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination training (ATRT)
Number of subjects: 52
Study 23463651 — intervention group
Group type: COMPARATOR
Intervention: Nonexercise control
Number of subjects: 52
Study 21321152 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-gradient severe aortic stenosis
Number of subjects: 1525
Study 21321152 — intervention group
Group type: COMPARATOR
Intervention: Moderate aortic stenosis
Number of subjects: 1525
Study 21321152 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-gradient severe aortic stenosis with reduced stroke volume index (≤ 35 mL/m²)
Number of subjects: 1525
Study 21321152 — intervention group
Group type: COMPARATOR
Intervention: Patients with normal stroke volume index
Number of subjects: 1525
Study 19064281 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 0
Study 19064281 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil
Number of subjects: 0
Study 19064281 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 16864815 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BTXA) 50 units/0.25 mL
Number of subjects: 30
Study 16864815 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline (0.25 mL)
Number of subjects: 30
Study 12615873 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin
Number of subjects: 938
Study 12615873 — intervention group
Group type: COMPARATOR
Intervention: Beta-lactam therapy (including cefuroxime and amoxicillin)
Number of subjects: 938
Study 12615873 — intervention group
Group type: COMPARATOR
Intervention: Cefuroxime
Number of subjects: 938
Study 12615873 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin
Number of subjects: 938
Study 12615873 — intervention group
Group type: COMPARATOR
Intervention: Beta-lactam therapy
Number of subjects: 938
Study 12615873 — intervention group
Group type: EXPERIMENTAL
Intervention: CDAD positive patients
Number of subjects: 938
Study 10844622 — intervention group
Group type: EXPERIMENTAL
Intervention: Essential amino acids (EAAs) 3.6 g three times daily with meals for three months
Number of subjects: 52
Study 10844622 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 10844622 — intervention group
Group type: EXPERIMENTAL
Intervention: Essential amino acids (EAAs)
Number of subjects: 52
Study 9228227 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional therapy with additional ultrasound treatment for 12 weeks (30 kHz continuous ultrasound 100 mW/cm2 three times a week)
Number of subjects: 24
Study 9228227 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy with topical application of hydrocolloid dressings and compression therapy
Number of subjects: 24
Study 8440857 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training
Number of subjects: 180
Study 8440857 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training
Number of subjects: 180
Study 8440857 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined endurance and strength training
Number of subjects: 180
Study 8440857 — intervention group
Group type: EXPERIMENTAL
Intervention: Stationary cycle
Number of subjects: 180
Study 8440857 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking
Number of subjects: 180
Study 8440857 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic movement
Number of subjects: 180
Study 3446491 — intervention group
Group type: EXPERIMENTAL
Intervention: Edrophonium 0.5 mg kg‐1
Number of subjects: 40
Study 3446491 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine 0.05 mg kg‐1
Number of subjects: 40
Study 3446491 — intervention group
Group type: EXPERIMENTAL
Intervention: Edrophonium 1.0 mg kg‐1
Number of subjects: 40
Study 29334721 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab (TCZ) 8 mg/kg intravenously every 4 weeks
Number of subjects: 0
Study 29334721 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 28376839 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitation
Number of subjects: 0
Study 28376839 — intervention group
Group type: COMPARATOR
Intervention: Implementation as Usual (IU)
Number of subjects: 0
Study 27061821 — intervention group
Group type: EXPERIMENTAL
Intervention: Mammographic screening every 18 months
Number of subjects: 11812
Study 27061821 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 11812
Study 23546863 — intervention group
Group type: EXPERIMENTAL
Intervention: Invaginating excision of hernia sac without ligation (Group I)
Number of subjects: 152
Study 23546863 — intervention group
Group type: EXPERIMENTAL
Intervention: Excision of the sac at the neck without ligation (Group E)
Number of subjects: 152
Study 23546863 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfixion and excision of the sac in the traditional manner (Group L)
Number of subjects: 152
Study 22937901 — intervention group
Group type: EXPERIMENTAL
Intervention: Alginate impression material
Number of subjects: 85
Study 22937901 — intervention group
Group type: COMPARATOR
Intervention: Silicone impression material
Number of subjects: 85
Study 22937901 — intervention group
Group type: COMPARATOR
Intervention: Health economic evaluation
Number of subjects: 85
Study 19437299 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 37
Study 17264541 — intervention group
Group type: COMPARATOR
Intervention: Nup88 expression in normal mucosa
Number of subjects: 315
Study 17264541 — intervention group
Group type: EXPERIMENTAL
Intervention: Nup88 expression in primary adenocarcinomas
Number of subjects: 315
Study 17264541 — intervention group
Group type: EXPERIMENTAL
Intervention: Nup88 expression in lymph node metastases
Number of subjects: 315
Study 17264541 — intervention group
Group type: EXPERIMENTAL
Intervention: Nup88 expression in ulcerated tumours
Number of subjects: 315
Study 17264541 — intervention group
Group type: EXPERIMENTAL
Intervention: Nup88 expression in tumours with different differentiation levels
Number of subjects: 315
Study 12445840 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose prednisone (initial dose: 20 mg/day, maintenance dose: 10 mg/day)
Number of subjects: 0
Study 12445840 — intervention group
Group type: EXPERIMENTAL
Intervention: Meta-analysis including data from three other AD trials
Number of subjects: 0
Study 12445840 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone treatment
Number of subjects: 0
Study 10863343 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 8717923 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation program
Number of subjects: 0
Study 8717923 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 0
Study 1279928 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusions of dextran-40 with pentoxifylline
Number of subjects: 382
Study 1279928 — intervention group
Group type: EXPERIMENTAL
Intervention: Saline infusions with pentoxifylline
Number of subjects: 382
Study 1279928 — intervention group
Group type: COMPARATOR
Intervention: Saline infusions with placebo medication
Number of subjects: 382
Study 6428171 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy with verapamil (360 mg daily) and atenolol (100 mg daily)
Number of subjects: 18
Study 6428171 — intervention group
Group type: COMPARATOR
Intervention: Single drug therapy (either verapamil or atenolol)
Number of subjects: 18
Study 3094443 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil (1.5 g) with probenecid (1 g)
Number of subjects: 117
Study 3094443 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin (3 g) with probenecid (1 g)
Number of subjects: 117
Study 31983031 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux-en-Y Gastric Bypass (RYGB)
Number of subjects: 19
Study 31983031 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care medical treatment (control)
Number of subjects: 19
Study 29886787 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcervical Foley catheter balloon with traction
Number of subjects: 200
Study 29886787 — intervention group
Group type: COMPARATOR
Intervention: Transcervical Foley catheter balloon without traction
Number of subjects: 200
Study 28089102 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid injection
Number of subjects: 44
Study 28089102 — intervention group
Group type: EXPERIMENTAL
Intervention: Polidocanol
Number of subjects: 44
Study 28089102 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous blood
Number of subjects: 44
Study 25707509 — intervention group
Group type: EXPERIMENTAL
Intervention: Basophil allergen threshold sensitivity (CD‐sens) to hazelnut
Number of subjects: 40
Study 25707509 — intervention group
Group type: EXPERIMENTAL
Intervention: IgE antibodies to hazelnut components (Cor a 9 and Cor a 14)
Number of subjects: 40
Study 25707509 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum tryptase levels
Number of subjects: 40
Study 23917675 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-directed therapy group
Number of subjects: 80
Study 23917675 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study 19415350 — intervention group
Group type: EXPERIMENTAL
Intervention: RelyX Unicem Applicator (RUA)
Number of subjects: 120
Study 19415350 — intervention group
Group type: EXPERIMENTAL
Intervention: G-Cem (GC)
Number of subjects: 120
Study 19415350 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearfil SA Cement (CSA)
Number of subjects: 120
Study 19415350 — intervention group
Group type: COMPARATOR
Intervention: Air-particle abrasion
Number of subjects: 120
Study 18209581 — intervention group
Group type: EXPERIMENTAL
Intervention: PPI (rabeprazole, lansoprazole, or omeprazole) plus amoxicillin and metronidazole given b.i.d. for 7 days
Number of subjects: 169
Study 18209581 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of metronidazole resistance
Number of subjects: 169
Study 17000910 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg/d
Number of subjects: 200
Study 17000910 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 17000910 — intervention group
Group type: EXPERIMENTAL
Intervention: High postoperative CRP levels
Number of subjects: 200
Study 17000910 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin 40 mg/d and Placebo
Number of subjects: 200
Study 14624763 — intervention group
Group type: EXPERIMENTAL
Intervention: Three times weekly GH injections
Number of subjects: 20
Study 14624763 — intervention group
Group type: COMPARATOR
Intervention: Daily GH injections
Number of subjects: 20
Study 11097698 — intervention group
Group type: COMPARATOR
Intervention: Ketamine
Number of subjects: 266
Study 11097698 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine and midazolam
Number of subjects: 266
Study 9112967 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbo-sacral selective posterior rhizotomy (SPR) plus intensive physiotherapy
Number of subjects: 30
Study 9112967 — intervention group
Group type: COMPARATOR
Intervention: Intensive physiotherapy alone
Number of subjects: 30
Study 1350364 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol 50 micrograms BID
Number of subjects: 2277
Study 1350364 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol 100 micrograms BID
Number of subjects: 2277
Study 1350364 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol
Number of subjects: 2277
Study 3919745 — intervention group
Group type: EXPERIMENTAL
Intervention: lysine acetyl salicylate (LAS)
Number of subjects: 30
Study 3919745 — intervention group
Group type: COMPARATOR
Intervention: morphine
Number of subjects: 30
Study 30379212 — intervention group
Group type: EXPERIMENTAL
Intervention: Osseotite
Number of subjects: 19
Study 30379212 — intervention group
Group type: EXPERIMENTAL
Intervention: Nanotite
Number of subjects: 19
Study 30379212 — intervention group
Group type: EXPERIMENTAL
Intervention: SLActive
Number of subjects: 19
Study 30379212 — intervention group
Group type: EXPERIMENTAL
Intervention: SLA
Number of subjects: 19
Study 27058471 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-week resilience program
Number of subjects: 28
Study 27058471 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 28
Study 24477299 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 g of ethanol/d as gin or beer
Number of subjects: 74
Study 24477299 — intervention group
Group type: COMPARATOR
Intervention: nonalcoholic beer
Number of subjects: 74